Home > NewsRelease > Pulling out all the stops for a COVID-19 vaccine
Text
Pulling out all the stops for a COVID-19 vaccine
From:
Michael D. Shaw -- Expert in Health Care and Environmental Affairs Michael D. Shaw -- Expert in Health Care and Environmental Affairs
For Immediate Release:
Dateline: Washington , DC
Saturday, June 13, 2020

 

Inovio-firsts-immuno-oncology

This HND piece puts the spotlight on an interesting approach to developing a COVID-19 vaccine: DNA medicine. The idea here is that DNA plasmids are introduced via a special device into the cell. There they trigger T cells to do their thing against the invading COVID virus. The company behind this unique approach is Inovio Pharmaceuticals.

Inovio has had some real success with MERS, caused by a related coronavirus, and initial studies look good for COVID. At present, Inovio is having some issues with one of its sub-contractors, and that is the subject of litigation, which hopefully should be resolved soon.

Read the complete article.

Interscan Corporation
4590 Ish Drive
Simi Valley, CA 93063-7682

Phone:    1 800 458-6153 (US and Canada)
               (818) 882-2331
Web:      www.halimeter.com
Interscan Twitter

News Media Interview Contact
Name: Michael D. Shaw
Title: Executive VP/Director of Marketing
Group: Interscan Corporation
Dateline: Reston, VA United States
Direct Phone: 703-796-6063
Main Phone: 1 800 458-6153
Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs
Contact Click to Contact